Why the study?
Does XNT prevent pulmonary hypertension in a monocrotaline-induced rat model?
Population
Monocrotaline-induced pulmonary hypertension rat model
Comparison
Chronic treatment with XNT (1-[… vs Monocrotaline-treated rats without XNT treatment
Design
Preclinical
Authors
Loading...
Supports ACE2 activation in experimental PH; hypothesis-generating for human disease with no current clinical implications.
Does XNT prevent pulmonary hypertension in a monocrotaline-induced rat model?
Activation of ACE2 by the small molecule XNT prevents the development of pulmonary hypertension in a rat model, suggesting a potential therapeutic target.
Ferreira et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: